Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Enzymatic Dynamic Kinetic Resolution. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN116024282B details enzymatic dynamic kinetic resolution for high purity S nornicotine offering cost reduction and supply chain reliability for pharmaceutical intermediates manufacturing.
Novel enzymatic dynamic kinetic resolution for high-purity (R)-praziquantel. Reduces cost and improves supply chain reliability for API manufacturing.
Patent CN117701649B reveals enzymatic DKR for Brivaracetam intermediates. Achieve 99% ee and reduced costs. Reliable pharmaceutical intermediate supplier for scale-up.
Patent CN110835639A reveals a dual-enzyme DKR process for high-purity (S)-tetrahydroisoquinoline derivatives, offering superior ee values and scalable manufacturing for pharmaceutical intermediates.
Patent CN110317849B reveals a high-yield enzymatic method for producing chiral tetrahydroisoquinoline intermediates, offering significant cost and purity advantages for pharmaceutical manufacturing.
Novel enzymatic resolution process ensures greater than 99 percent ee value. Cost-effective Raney nickel catalyst reduces manufacturing expenses for reliable supply chain partners.
Patent CN104178548A details high-purity S-2-naphthylethylamine synthesis via lipase. Offers cost reduction and supply reliability for pharmaceutical intermediate manufacturing.
Patent CN104178546A details high-yield enzymatic resolution for S-1-naphthylethylamine. Offers superior purity and supply chain reliability for pharmaceutical intermediate manufacturing.
Patent CN104557911B reveals enzymatic deracemization for levo-praziquantel. Achieve high optical purity and cost reduction in pharmaceutical intermediates manufacturing with scalable green chemistry.